Evidence map›Paper›PMID 36599851›Full record

ArticleNature communications2023

Rapid, label-free histopathological diagnosis of liver cancer based on Raman spectroscopy and deep learning.

Liping Huang, Hongwei Sun, Liangbin Sun, Keqing Shi, Yuzhe Chen, Xueqian Ren, Yuancai Ge, Danfeng Jiang, Xiaohu Liu, Wolfgang Knoll and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Virtual histology imaging of lymph nodesCancer biology & medicine · 2026
    Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Liping HuangSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.ORCID 0000-0002-3094-7815
Hongwei SunThe First Affiliated Hospital of Wenzhou Medical University, 325015, Wenzhou, PR China.
Liangbin SunSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.
Keqing ShiThe First Affiliated Hospital of Wenzhou Medical University, 325015, Wenzhou, PR China.
Yuzhe ChenSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.
Xueqian RenSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.
Yuancai GeSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.
Danfeng JiangEngineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences, 325001, Wenzhou, PR China.
Xiaohu LiuSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China.
Wolfgang KnollAustrian Institute of Technology, Giefinggasse 4, Vienna, 1210, Austria.
Qingwen ZhangEngineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences, 325001, Wenzhou, PR China. zhangqw@wiucas.ac.cn.ORCID 0000-0002-9951-4620
Yi WangSchool of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, 325001, Wenzhou, PR China. yiwang@wmu.edu.cn.ORCID 0000-0002-2110-623X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biopsy is the recommended standard for pathological diagnosis of liver carcinoma. However, this method usually requires sectioning and staining, and well-trained pathologists to interpret tissue images. Here, we utilize Raman spectroscopy to study human hepatic tissue samples, developing and validating a workflow for in vitro and intraoperative pathological diagnosis of liver cancer. We distinguish carcinoma tissues from adjacent non-tumour tissues in a rapid, non-disruptive, and label-free manner by using Raman spectroscopy combined with deep learning, which is validated by tissue metabolomics. This technique allows for detailed pathological identification of the cancer tissues, including subtype, differentiation grade, and tumour stage. 2D/3D Raman images of unprocessed human tissue slices with submicrometric resolution are also acquired based on visualization of molecular composition, which could assist in tumour boundary recognition and clinicopathologic diagnosis. Lastly, the potential for a portable handheld Raman system is illustrated during surgery for real-time intraoperative human liver cancer diagnosis.

Indexed as

Carcinoma, HepatocellularDeep LearningLiver NeoplasmsBiopsyHumansSpectrum Analysis, Raman

Identifiers

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.